메뉴 건너뛰기




Volumn 8, Issue 7-8, 1996, Pages 281-286

Novel Taxol® formulation: Polyvinylpyrrolidone nanoparticle- encapsulated Taxol® for drug delivery in cancer therapy

Author keywords

cancer therapy; drug delivery; melanoma; nanoparticles; polyvinylpyrrolidone; Taxol

Indexed keywords

CREMOPHOR; NANOPARTICLE; PACLITAXEL; POVIDONE IODINE; ANTINEOPLASTIC AGENT; POVIDONE;

EID: 0029658463     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (104)

References (31)
  • 1
    • 0028294619 scopus 로고
    • Paclitaxel (Taxol): A novel anticancer chemotherapeutic drug
    • 1. Long, H. J. Paclitaxel (Taxol): a novel anticancer chemotherapeutic drug. Mayo Clin. Proc. 69:341-345; 1994.
    • (1994) Mayo Clin. Proc. , vol.69 , pp. 341-345
    • Long, H.J.1
  • 2
    • 0028040316 scopus 로고
    • Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors
    • 2. Cahan, M. A.; Walter, K. A., Colvin, O. M.; Brem, H. Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors. Cancer Chemother. Pharmacol. 33: 441-444; 1994.
    • (1994) Cancer Chemother. Pharmacol. , vol.33 , pp. 441-444
    • Cahan, M.A.1    Walter, K.A.2    Colvin, O.M.3    Brem, H.4
  • 5
    • 0027950826 scopus 로고
    • Taxol (paclitaxel): A novel anti-microtubule agent with remarkable anti-neoplastic activity
    • 5. Fao, R.; Norton, L.; Seidman, A. D. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int. J. Clin. Lab. Res. 24:6-14; 1994.
    • (1994) Int. J. Clin. Lab. Res. , vol.24 , pp. 6-14
    • Fao, R.1    Norton, L.2    Seidman, A.D.3
  • 7
    • 0027055485 scopus 로고
    • Phase II study and long term followup of patients treated with Taxol for advanced ovarian adenocarcinoma
    • 7. Enzig, A. I.; Wiernik, P. H.; Sasloff, J. Garl, S.; Runowicz, C.; O'Hanlon, K. A.; Goldberg, G. Phase II study and long term followup of patients treated with Taxol for advanced ovarian adenocarcinoma. J. Clin. Oncol. 10:1748-1753; 1992.
    • (1992) J. Clin. Oncol. , vol.10 , pp. 1748-1753
    • Enzig, A.I.1    Wiernik, P.H.2    Sasloff, J.3    Garl, S.4    Runowicz, C.5    O'Hanlon, K.A.6    Goldberg, G.7
  • 8
    • 0027688126 scopus 로고
    • Taxol: A promising new drug of the 90's
    • 8. Rogers, B. B. Taxol: a promising new drug of the 90's. Oncol. Nurs. Forum 20:1483-1489; 1993.
    • (1993) Oncol. Nurs. Forum , vol.20 , pp. 1483-1489
    • Rogers, B.B.1
  • 10
    • 0027137936 scopus 로고
    • Antitumor effect of Taxol-containing liposomes in a Taxol-resistant murine tumor model
    • 10. Sharma, A.; Maythew, E.; Straubinger, R. M. Antitumor effect of Taxol-containing liposomes in a Taxol-resistant murine tumor model. Cancer Res. 53: 5877-5881; 1993.
    • (1993) Cancer Res. , vol.53 , pp. 5877-5881
    • Sharma, A.1    Maythew, E.2    Straubinger, R.M.3
  • 12
    • 0011871708 scopus 로고
    • Liposomes: A kinetic study. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol
    • 12. Hwang, K. L.; Luk, K. K.; Beaumier, P. L. Liposomes: a kinetic study. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol. Proc. Natl. Acad. Sci. USA 77:4030-4034; 1980.
    • (1980) Proc. Natl. Acad. Sci. USA , vol.77 , pp. 4030-4034
    • Hwang, K.L.1    Luk, K.K.2    Beaumier, P.L.3
  • 14
    • 0024551243 scopus 로고
    • Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues
    • 14. Allen, T. M.; Hansen, C.; Rutledge, J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 981:27-35; 1989.
    • (1989) Biochim. Biophys. Acta , vol.981 , pp. 27-35
    • Allen, T.M.1    Hansen, C.2    Rutledge, J.3
  • 15
    • 0026352832 scopus 로고
    • Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
    • 15. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88:11460-11464; 1991.
    • (1991) Proc. Natl. Acad. Sci. USA , vol.88 , pp. 11460-11464
    • Papahadjopoulos, D.1    Allen, T.M.2    Gabizon, A.3
  • 16
    • 0026603586 scopus 로고
    • Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
    • 16. Gabizon, A. A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52: 2431-2439; 1992.
    • (1992) Cancer Res. , vol.52 , pp. 2431-2439
    • Gabizon, A.A.1
  • 17
    • 0026751917 scopus 로고
    • Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes
    • 17. Vaage, J.; Mayhew, E.; Lasic, D.; Martin, F. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes. Int. J. Cancer 51:942-948; 1992.
    • (1992) Int. J. Cancer , vol.51 , pp. 942-948
    • Vaage, J.1    Mayhew, E.2    Lasic, D.3    Martin, F.4
  • 18
    • 0018250922 scopus 로고
    • Design of liposomes for enhanced local release of drugs by hyperthermia
    • 18. Yatvin, M. B. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202: 1290-1292; 1978.
    • (1978) Science , vol.202 , pp. 1290-1292
    • Yatvin, M.B.1
  • 19
    • 0029130453 scopus 로고
    • Designing of heat sensitive liposomes from natural lipids for multimodality cancer therapy
    • 19. Chelvi, T. P.; Ralhan, R. Designing of heat sensitive liposomes from natural lipids for multimodality cancer therapy. Int. J. Hyperthermia 11:685-695; 1995.
    • (1995) Int. J. Hyperthermia , vol.11 , pp. 685-695
    • Chelvi, T.P.1    Ralhan, R.2
  • 20
    • 0028856849 scopus 로고
    • Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors
    • 20. Chelvi, T. P.; Jain, S. K.; Ralhan, R. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors. Oncol. Res. 7:393-398; 1995.
    • (1995) Oncol. Res. , vol.7 , pp. 393-398
    • Chelvi, T.P.1    Jain, S.K.2    Ralhan, R.3
  • 22
    • 0021368395 scopus 로고
    • The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338)
    • 22. Illum, L.; Davis, S. S. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338). FEBS Lett. 167: 79-82; 1984.
    • (1984) FEBS Lett. , vol.167 , pp. 79-82
    • Illum, L.1    Davis, S.S.2
  • 23
    • 34249762091 scopus 로고
    • Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase
    • 23. Munshi, N.; Chakravorty K.; De, T. K.; Maitra, A. N. Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase. Colloid Polym. Sci. 273: 464-472; 1995.
    • (1995) Colloid Polym. Sci. , vol.273 , pp. 464-472
    • Munshi, N.1    Chakravorty, K.2    De, T.K.3    Maitra, A.N.4
  • 24
    • 0011830663 scopus 로고
    • Cancer incidence and mortality trends
    • 24. Bite, S. Cancer incidence and mortality trends. J. Natl. Cancer Inst. 84:1862-1866; 1992.
    • (1992) J. Natl. Cancer Inst. , vol.84 , pp. 1862-1866
    • Bite, S.1
  • 26
    • 0027764256 scopus 로고
    • Novel preparation of poly (vinylalcohol) microparticles without crosslinking agent for controlled drug delivery of proteins
    • 26. Ficek, B. J.; Peppas, N. A. Novel preparation of poly (vinylalcohol) microparticles without crosslinking agent for controlled drug delivery of proteins. J. Controlled Release 27:259-264; 1993.
    • (1993) J. Controlled Release , vol.27 , pp. 259-264
    • Ficek, B.J.1    Peppas, N.A.2
  • 28
    • 0026586604 scopus 로고
    • In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery
    • 28. Shalaby, W. S. W.; Blevins, W. E.; Park, K. In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery. J. Controlled Release 19:131-144; 1992.
    • (1992) J. Controlled Release , vol.19 , pp. 131-144
    • Shalaby, W.S.W.1    Blevins, W.E.2    Park, K.3
  • 29
    • 0027982550 scopus 로고
    • Pharmacokinetics in design of polymeric drug delivery systems
    • 29. Hashida, M.; Takakura, Y. Pharmacokinetics in design of polymeric drug delivery systems. J. Controlled Release 31:163-171; 1994.
    • (1994) J. Controlled Release , vol.31 , pp. 163-171
    • Hashida, M.1    Takakura, Y.2
  • 30
    • 0023130497 scopus 로고
    • Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages
    • 30. Illum, L.; Jacobsen, L. O.; Muler, R. H.; Mak, E.; Davis, S. S. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8:113-117; 1987.
    • (1987) Biomaterials , vol.8 , pp. 113-117
    • Illum, L.1    Jacobsen, L.O.2    Muler, R.H.3    Mak, E.4    Davis, S.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.